Literature DB >> 8549288

Classification and structure-activity relationships of fluoroquinolones.

A Bryskier1, J F Chantot.   

Abstract

Fluoroquinolones are potent broad spectrum antibacterial agents. Two classifications have been described: chemical and biological. Quinolones can be classified into 4 groups according to their chemical structures: monocyclic, bicyclic, tricyclic and tetracyclic derivatives. Each group can be subdivided into subgroups if a fluorine atom is fixed at the 6-position. The biological classification recognised 4 groups. Groups 1 and 2 are composed of compounds showing limited spectra (Enterobacteriaceae) and groups 3 and 4 contain compounds displaying broad antibacterial spectra. Compounds that are highly metabolised fall into groups 1 and 3 and those poorly metabolised (< 5%) into groups 2 and 4. The structure of fluoroquinolones may help to predict antibacterial activity, pharmacokinetics, physicochemical properties, toxicity and adverse events.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8549288     DOI: 10.2165/00003495-199500492-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

Review 1.  Structure-activity relationships of the fluoroquinolones.

Authors:  D T Chu; P B Fernandes
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

Review 2.  Recent advances in structure activity relationships in new quinolones.

Authors:  Y Asahina; T Ishizaki; S Suzue
Journal:  Prog Drug Res       Date:  1992

Review 3.  Development of antibacterial agents of the nalidixic acid type.

Authors:  R Albrecht
Journal:  Prog Drug Res       Date:  1977

4.  Enoxacin raises plasma theophylline concentrations.

Authors:  W J Wijnands; C L van Herwaarden; T B Vree
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

5.  Monocyclic and tricyclic analogs of quinolones: mechanism of action.

Authors:  N H Georgopapadakou; B A Dix; P Angehrn; A Wick; G L Olson
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Synthesis, antibacterial activities, and pharmacological properties of enantiomers of temafloxacin hydrochloride.

Authors:  D T Chu; C W Nordeen; D J Hardy; R N Swanson; W J Giardina; A G Pernet; J J Plattner
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

7.  Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids.

Authors:  S Inoue; T Ohue; J Yamagishi; S Nakamura; M Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

Review 8.  Drug interactions with quinolones.

Authors:  R Janknegt
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

Review 9.  Structure-activity and structure-side-effect relationships for the quinolone antibacterials.

Authors:  J M Domagala
Journal:  J Antimicrob Chemother       Date:  1994-04       Impact factor: 5.790

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more
  13 in total

Review 1.  Quinolones: which generation for which microbe?

Authors:  M K Lee; M S Kanatani
Journal:  West J Med       Date:  1999-06

2.  Detection and prevention of ocular phototoxicity of ciprofloxacin and other fluoroquinolone antibiotics.

Authors:  Baozhong Zhao; Colin F Chignell; Mustapha Rammal; Frank Smith; Mary G Hamilton; Usha P Andley; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2010-06-01       Impact factor: 3.421

3.  Engineering the specificity of antibacterial fluoroquinolones: benzenesulfonamide modifications at C-7 of ciprofloxacin change its primary target in Streptococcus pneumoniae from topoisomerase IV to gyrase.

Authors:  F L Alovero; X S Pan; J E Morris; R H Manzo; L M Fisher
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

4.  Prediction of quinolone activity against Mycobacterium avium by molecular topology and virtual computational screening.

Authors:  R Gozalbes; M Brun-Pascaud; R García-Domenech; J Gálvez; P M Girard; J P Doucet; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Anti-toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques.

Authors:  R Gozalbes; M Brun-Pascaud; R Garcia-Domenech; J Galvez; P M Girard; J P Doucet; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  The new fluoroquinolones: A critical review.

Authors:  G G Zhanel; A Walkty; L Vercaigne; J A Karlowsky; J Embil; A S Gin; D J Hoban
Journal:  Can J Infect Dis       Date:  1999-05

Review 7.  Safety profile of the fluoroquinolones: focus on levofloxacin.

Authors:  Hans H Liu
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

Review 8.  A critical review of the fluoroquinolones: focus on respiratory infections.

Authors:  George G Zhanel; Kelly Ennis; Lavern Vercaigne; Andrew Walkty; Alfred S Gin; John Embil; Heather Smith; Daryl J Hoban
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Safety of fluoroquinolones: An update.

Authors:  L Mandell; G Tillotson
Journal:  Can J Infect Dis       Date:  2002-01

10.  Mechanism underlying levofloxacin uptake by human polymorphonuclear neutrophils.

Authors:  D Vazifeh; A Bryskier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.